Modeling household dynamics on Respiratory Syncytial Virus (RSV)

Modeling household dynamics on Respiratory Syncytial Virus (RSV)

Respiratory Syncytial Virus (RSV) is the most common cause of respiratory tract infection in infants and children and shows increasing trend among elderly people worldwide. In many developing country settings, population and household structures have gone through some significant changes in the past...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Mahikul, W, White, L, Poovorawan, K, Soonthornworasiri, N, Sukontamarn, P, Chanthavilay, P, F Medley, G, Pan-Ngum, W
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	Public Library of Science 2019

Míreanna comhchosúla

Modeling household dynamics on Respiratory Syncytial Virus (RSV).
de réir: Wiriya Mahikul, et al.
Foilsithe / Cruthaithe: (2019-01-01)

Modelling population dynamics and seasonal movement to assess and predict the burden of melioidosis
de réir: Mahikul, W, et al.
Foilsithe / Cruthaithe: (2019)

A population dynamic model to assess the diabetes screening and reporting programs and project the burden of undiagnosed diabetes in Thailand
de réir: Mahikul, W, et al.
Foilsithe / Cruthaithe: (2019)

Modelling population dynamics and seasonal movement to assess and predict the burden of melioidosis.
de réir: Wiriya Mahikul, et al.
Foilsithe / Cruthaithe: (2019-05-01)

Pathobiology of Respiratory Syncytial Virus (RSV)
de réir: Ralph A. Tripp, et al.
Foilsithe / Cruthaithe: (2020-07-01)

Respiratory Syncytial Virus (RSV) Update
de réir: Leonard R. Krilov, et al.
Foilsithe / Cruthaithe: (2022-09-01)

Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting
de réir: Kinyanjui, T, et al.
Foilsithe / Cruthaithe: (2020)

The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England and Wales and Finland: seasonality and cross-protection.
de réir: White, L, et al.
Foilsithe / Cruthaithe: (2005)

Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication
de réir: Jackelyn Murray, et al.
Foilsithe / Cruthaithe: (2022-04-01)

The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England & Wales and Finland: seasonality and cross-protection
de réir: White, L, et al.
Foilsithe / Cruthaithe: (2005)

Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)
de réir: Dvir Gatt, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach.
de réir: Pan-Ngum, W, et al.
Foilsithe / Cruthaithe: (2016)

Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting
de réir: Timothy Kinyanjui, et al.
Foilsithe / Cruthaithe: (2020-04-01)

The Development of Animal Models for Respiratory Syncytial Virus (RSV) Infection and Enhanced RSV Disease
de réir: Gengxin Zhang, et al.
Foilsithe / Cruthaithe: (2024-10-01)

Epidemiological changes of respiratory syncytial virus (RSV) infections in Israel.
de réir: Shira Hirsh, et al.
Foilsithe / Cruthaithe: (2014-01-01)

Polymyalgia rheumatica following respiratory syncytial virus (RSV) vaccination
de réir: Mohamad El Labban, et al.
Foilsithe / Cruthaithe: (2024-06-01)

Perinatal Lamb Model of Respiratory Syncytial Virus (RSV) Infection
de réir: Mark R. Ackermann, et al.
Foilsithe / Cruthaithe: (2012-10-01)

Reducing respiratory syncytial virus (RSV) hospitalization in a lower-income country by vaccinating mothers-to-be and their households
de réir: Samuel PC Brand, et al.
Foilsithe / Cruthaithe: (2020-03-01)

Effects of formalin-inactivated respiratory syncytial virus (FI-RSV) in the perinatal lamb model of RSV.
de réir: Rachel J Derscheid, et al.
Foilsithe / Cruthaithe: (2013-01-01)

Antibody gene transfer for prophylaxis of respiratory syncytial virus (RSV) infection
de réir: Antepowicz, A, et al.
Foilsithe / Cruthaithe: (2018)

Monoterpene-Containing Substituted Coumarins as Inhibitors of Respiratory Syncytial Virus (RSV) Replication
de réir: Tatyana M. Khomenko, et al.
Foilsithe / Cruthaithe: (2021-12-01)

Respiratory syncytial virus (RSV) bronchiolitis: comparative study of RSV groups A and B infected children
de réir: Selir M. Straliotto, et al.
Foilsithe / Cruthaithe: (1994-03-01)

Respiratory syncytial virus (RSV) bronchiolitis: comparative study of RSV groups A and B infected children
de réir: Selir M. Straliotto, et al.
Foilsithe / Cruthaithe: (1994-03-01)

Effects of palivizumab prophylaxis on respiratory syncytial virus (RSV) infections in Montenegro
de réir: Envera Lekic, et al.
Foilsithe / Cruthaithe: (2024-05-01)

COVID-19 Lesson for Respiratory Syncytial Virus (RSV): Hygiene Works
de réir: Andrea Gastaldi, et al.
Foilsithe / Cruthaithe: (2021-12-01)

Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein
de réir: Harrison C. Bergeron, et al.
Foilsithe / Cruthaithe: (2023-04-01)

Anti-RSV Peptide-Loaded Liposomes for the Inhibition of Respiratory Syncytial Virus
de réir: Sameer Joshi, et al.
Foilsithe / Cruthaithe: (2018-05-01)

Defining the timing of respiratory syncytial virus (RSV) outbreaks: an epidemiological study
de réir: Enders Martin, et al.
Foilsithe / Cruthaithe: (2005-03-01)

Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B.
de réir: Anne M Hause, et al.
Foilsithe / Cruthaithe: (2017-01-01)

Model-based estimates of transmission of respiratory syncytial virus within households
de réir: Ivy K. Kombe, et al.
Foilsithe / Cruthaithe: (2019-06-01)

Correction: Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B.
de réir: Anne M Hause, et al.
Foilsithe / Cruthaithe: (2017-01-01)

Modelling the household-level impact of a maternal respiratory syncytial virus (RSV) vaccine in a high-income setting
de réir: Patricia T. Campbell, et al.
Foilsithe / Cruthaithe: (2020-11-01)

New Inhibitors of Respiratory Syncytial Virus (RSV) Replication Based on Monoterpene-Substituted Arylcoumarins
de réir: Tatyana M. Khomenko, et al.
Foilsithe / Cruthaithe: (2023-03-01)

Priorities for developing respiratory syncytial virus (RSV) vaccines in different target populations
de réir: Drysdale, S, et al.
Foilsithe / Cruthaithe: (2020)

Impact of Respiratory Syncytial Virus (RSV) in Adults 60 Years and Older in Spain
de réir: Sara Jimeno Ruiz, et al.
Foilsithe / Cruthaithe: (2024-11-01)

Burden of respiratory syncytial virus (RSV) infection in Germany: a systematic review
de réir: Anahita Poshtiban, et al.
Foilsithe / Cruthaithe: (2024-08-01)

Pricey or priceless: cost-effectiveness of respiratory syncytial virus (RSV) prevention in infants
de réir: Xiao Li, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
de réir: Asunci&oacute;n Mej&iacute;as, et al.
Foilsithe / Cruthaithe: (2008-09-01)

Review of the Safety, Efficacy and Tolerability of Palivizumab in the Prevention of Severe Respiratory Syncytial Virus (RSV) Disease
de réir: O'Hagan S, et al.
Foilsithe / Cruthaithe: (2023-09-01)

Olfactomedin 4 Serves as a Marker for Disease Severity in Pediatric Respiratory Syncytial Virus (RSV) Infection.
de réir: H K Brand, et al.
Foilsithe / Cruthaithe: (2015-01-01)